Physician profile
Marcus H Cornwall
NPI 1689639841
$10,719.20
in general payments reported to CMS, 2019-2025
56 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $1,598 · 2021: $1,690 · 2022: $1,619 · 2023: $1,624 · 2024: $1,869 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,155.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,623.28 | 2020-2025 | Qulipta, Ubrelvy, Vraylar |
| Astrazeneca Pharmaceuticals LP | $1,080.29 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $690.63 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $654.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $583.04 | 2020-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Pfizer INC. | $539.87 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $477.10 | 2022-2025 | |
| Amarin Pharma, INC. | $436.27 | 2019-2021 | |
| Aimmune Therapeutics, INC. | $426.80 | 2024-2025 | Zenpep, Vowst |
| Nestle Healthcare Nutrition INC. | $389.19 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $351.91 | 2019-2021 | |
| Amgen INC. | $238.40 | 2020-2024 | Repatha, Otezla |
| Lundbeck LLC | $187.41 | 2020-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $183.11 | 2022-2025 | Belsomra, M-M-R II, Gardasil 9 |
| Exact Sciences Corporation | $166.91 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Cornwall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.